Synovitis is inflammation of the synovial membrane, the thin tissue that lines the inside of most joints. This membrane normally produces a small amount of fluid that lubricates the joint and helps it move smoothly. When it becomes inflamed, it thickens, swells, and produces excess fluid, causing pain, stiffness, and visible swelling around the affected joint.
What Happens Inside the Joint
The synovial membrane is only a few cells thick under normal conditions. In synovitis, that lining grows thicker as cells multiply, a process called synovial hyperplasia. At the same time, immune cells (primarily certain white blood cells called macrophages and lymphocytes) migrate into the tissue. New blood vessels form within the membrane, and in longer-lasting cases, the tissue can become scarred and fibrotic.
The immune cells clustered in the inflamed membrane release a cascade of inflammatory signaling molecules. These molecules break down cartilage, irritate nerve endings, and draw still more immune cells into the joint. In autoimmune forms of synovitis, the process becomes self-sustaining: the immune system continues attacking the joint lining even after the original trigger is gone, which is why conditions like rheumatoid arthritis cause progressive joint damage over time.
Common Symptoms
Synovitis typically causes a recognizable cluster of symptoms in the affected joint:
- Swelling that may feel soft or “boggy” around the joint
- Warmth or a hot feeling over the skin
- Pain that worsens with movement or pressure
- Stiffness, especially after periods of rest
- Reduced range of motion, making it harder to fully bend or extend the joint
These symptoms can develop gradually or come on quickly, depending on the cause. If left untreated, prolonged synovitis can permanently limit how far a joint moves by damaging cartilage and surrounding structures.
What Causes Synovitis
Synovitis isn’t a single disease. It’s a tissue response that can be triggered by a wide range of conditions.
Autoimmune diseases are among the most common causes. Rheumatoid arthritis, which affects roughly 1% of people worldwide, is defined by chronic synovial inflammation. In RA, the immune system’s T cells migrate into the joint lining, activate other immune cells, and drive ongoing tissue destruction. Psoriatic arthritis and lupus also produce synovitis through similar autoimmune mechanisms.
Osteoarthritis was once thought of as purely a “wear and tear” disease, but research over the past few decades has shown that synovial inflammation plays a significant role. Fragments of damaged cartilage and bone float into the joint fluid and trigger immune receptors on the synovial membrane. The resulting inflammation can look surprisingly similar to what happens in rheumatoid arthritis, though it tends to be less intense and follows a different pattern. The inflammatory process in osteoarthritis can appear in both early and late stages of the disease.
Infection is another important trigger. Bacteria, viruses, or fungi that enter a joint (through a wound, surgery, or the bloodstream) cause septic arthritis, which produces rapid, severe synovitis. This is a medical emergency because the infection can destroy a joint within days.
Crystal deposits from gout (uric acid crystals) or pseudogout (calcium crystals) irritate the synovium and cause intense, episodic inflammation. Injuries, repetitive overuse, and even allergic reactions can also trigger synovitis.
How Synovitis Differs Across Conditions
Although inflamed synovium can look similar across diseases, there are meaningful differences. In rheumatoid arthritis, the membrane contains higher concentrations of certain immune cells, particularly T cells and B cells, and the blood vessels within it tend to be straight. In spondyloarthropathies (a family of conditions including ankylosing spondylitis), the blood vessels are more tortuous and twisted, and overall blood supply to the synovium is greater. These differences help pathologists and rheumatologists distinguish between conditions when a tissue sample is examined.
Interestingly, research published in the Annals of the Rheumatic Diseases found that the appearance of the synovial membrane depends more on how active the disease is at that moment than on how long someone has had it. Patients without active joint swelling showed few differences between diseases, while those with active inflammation showed clear, disease-specific patterns.
How Synovitis Is Diagnosed
Diagnosis starts with a physical exam, where a provider checks for swelling, warmth, tenderness, and restricted movement. But confirming synovitis and distinguishing it from other causes of joint swelling often requires imaging or fluid analysis.
Ultrasound is widely used because it can detect synovial thickening in real time. The key diagnostic finding is thickened synovial tissue, not just fluid in the joint. Fluid alone is not enough to confirm synovitis. The severity is graded on a 0 to 3 scale based on how much the synovium has thickened and how much blood flow is visible on Doppler imaging. A grade 0 means no thickening or abnormal blood flow; grade 3 means severe thickening with marked blood flow, indicating highly active inflammation.
MRI provides a more detailed view and can show early cartilage damage, bone erosion, and the extent of synovial involvement. For suspected infections, a sample of joint fluid is drawn with a needle and analyzed. White blood cell counts above about 3,000 cells per microliter, with more than 75% of a particular cell type called neutrophils, strongly suggest infection or severe inflammation. Counts below 1,500 cells per microliter generally help rule it out.
Treatment Options
Treatment depends entirely on the underlying cause, but the immediate goal is always the same: reduce inflammation to relieve pain and prevent joint damage.
Anti-inflammatory medications are the first step for most people. Over-the-counter or prescription options taken by mouth or applied as a topical gel can reduce pain and swelling, though the relief tends to be temporary, especially in osteoarthritis-related synovitis. For inflammation limited to one or two joints, a corticosteroid injection delivered directly into the joint can provide targeted relief that lasts weeks to months. This approach is particularly useful when oral medications aren’t enough or aren’t well tolerated.
When synovitis is driven by an autoimmune disease like rheumatoid arthritis, treatment goes beyond managing symptoms. Disease-modifying medications work to calm the overactive immune response and slow joint destruction. These are typically started early in the disease course because the longer synovitis persists, the more permanent damage accumulates. For gout-related synovitis, treatment focuses on lowering uric acid levels to prevent crystal formation in the first place.
In cases where medications fail to control the inflammation, surgical removal of the inflamed synovial tissue (synovectomy) is an option. This is most often done arthroscopically through small incisions. The procedure doesn’t cure the underlying disease, but it can significantly reduce pain and swelling when the synovium itself has become so damaged and thickened that it’s a constant source of inflammation.
Transient Synovitis in Children
One form of synovitis deserves special mention because it’s common, alarming to parents, and almost always harmless. Transient synovitis of the hip typically affects children between ages 3 and 10. A child may suddenly start limping, complain of hip or knee pain, or have trouble standing. The cause is unknown, though it often follows a viral illness.
Despite the dramatic presentation, transient synovitis resolves on its own within one to two weeks. Rest and basic pain relief are usually all that’s needed. The main concern is ruling out a septic (infected) joint, which looks similar at first but requires urgent treatment. If a child has a fever along with joint pain and swelling, prompt evaluation is important.
Pigmented Villonodular Synovitis
A rare form called pigmented villonodular synovitis (PVNS) involves abnormal, tumor-like growths on the synovial membrane. It affects roughly 9 new people per million each year in the United States. Unlike other forms of synovitis, standard blood markers for inflammation are usually normal, which can delay diagnosis. Patients often go through extensive testing before the condition is identified.
The hallmark of PVNS is repeated bleeding into the joint, which leaves characteristic iron deposits in the tissue. Joint fluid drawn from an affected joint is typically dark brown or bloody rather than the clear, straw-colored fluid seen normally. MRI shows a distinctive pattern of joint swelling, iron deposits, and sometimes bone erosion. Treatment usually involves surgical removal of the abnormal tissue, though recurrence is possible.